Advertisement

Adaptive Biotechnologies Corporation ADPT

Set alert

Price alert · ADPT

All alert types
26.64 USD -1.53 -5.43%

At close · Oct 30

26.64 0.00 0.00%

After hours · Oct 30, 4:12 PM ET

Bid
26.61 × 2
Ask
26.64 × 2
26.17 Day range 27.97
12.41 52-week range 29.84
YTD
+64.04%
1 year
+57.54%
Open
27.36
Prev close
28.17
Mkt cap
4.25B
Vol
4.26M
Avg vol
2.15M
EPS
-0.41
P/E
0.00
Div yield
0.00%
More statistics
Low
26.17
High
27.97
Forward P/E
-147.76
Beta
2.10
Short ratio
4.56
Inst. own
99.06%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
26.35
200-d avg
19.56
1y target
30.21

2Y chart

Chart tools
Interval

Events in this range
  • Aug 5, 2025Earnings: -0.17; estimate -0.24; surprise 29.17%
  • Nov 6, 2025Earnings: 0.06; estimate -0.18; surprise 133.33%
  • Feb 5, 2026Earnings: -0.09; estimate -0.19; surprise 52.63%
  • May 5, 2026Earnings: -0.13; estimate -0.16; surprise 18.75%
  • Jul 28, 2026Earnings: -0.25; estimate -0.13361; surprise -87.11%
  • Aug 4, 2026Rating: Piper Sandler · Overweight → Overweight
  • Sep 22, 2026Rating: BTIG · Buy → Buy
  • Sep 29, 2026Rating: Goldman Sachs · — → Buy
  • Oct 1, 2026Rating: Guggenheim · Buy → Buy
  • Oct 13, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • Oct 13, 2026Rating: TD Cowen · Buy → Buy
Signals (115)
NameDateAgo
MACD: Buy SignalOct 27, 20265 days ago
SMA: BullishOct 26, 20266 days ago
SMA: BearishOct 12, 20262 weeks ago
MACD: Sell SignalOct 6, 20263 weeks ago
MACD: Buy SignalOct 5, 20263 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
RSI: OverboughtSep 24, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
RSI: OverboughtSep 16, 20261 month ago
MACD: Sell SignalAug 14, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
MACD: Sell SignalAug 6, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
MACD: Sell SignalJul 20, 20263 months ago
MACD: Buy SignalJul 17, 20263 months ago
MACD: Sell SignalJul 10, 20263 months ago
RSI: OverboughtJun 25, 20264 months ago
MACD: Buy SignalJun 24, 20264 months ago
MACD: Sell SignalJun 23, 20264 months ago
RSI: OverboughtJun 11, 20264 months ago
RSI: OverboughtJun 4, 20265 months ago
SMA: BullishJun 3, 20265 months ago
SMA: BearishJun 2, 20265 months ago
SMA: BullishJun 1, 20265 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BearishMay 27, 20265 months ago
MACD: Buy SignalMay 21, 20265 months ago
SMA: BullishMay 20, 20265 months ago
MACD: Sell SignalMay 11, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BullishMay 6, 20265 months ago
SMA: BearishMay 5, 20266 months ago
SMA: BullishMay 4, 20266 months ago
MACD: Buy SignalApr 30, 20266 months ago
MACD: Sell SignalApr 29, 20266 months ago
SMA: BearishApr 9, 20266 months ago
SMA: BullishApr 8, 20266 months ago
SMA: BearishApr 6, 20266 months ago
SMA: BullishApr 2, 20267 months ago
MACD: Buy SignalMar 31, 20267 months ago
MACD: Sell SignalMar 30, 20267 months ago
MACD: Buy SignalMar 24, 20267 months ago
RSI: OversoldMar 12, 20267 months ago
SMA: BearishMar 11, 20267 months ago
MACD: Sell SignalMar 6, 20268 months ago
MACD: Buy SignalFeb 26, 20268 months ago
SMA: BearishFeb 4, 20269 months ago
MACD: Sell SignalFeb 4, 20269 months ago
SMA: BullishJan 12, 20269 months ago
MACD: Buy SignalJan 12, 20269 months ago
SMA: BearishJan 8, 20269 months ago
SMA: BullishJan 7, 20269 months ago
MACD: Sell SignalDec 31, 202510 months ago
SMA: BearishDec 30, 202510 months ago
MACD: Buy SignalDec 22, 202510 months ago
SMA: BullishDec 18, 202510 months ago
SMA: BearishDec 5, 202511 months ago
MACD: Sell SignalDec 5, 202511 months ago
RSI: OverboughtNov 24, 202511 months ago
MACD: Buy SignalNov 21, 202511 months ago
SMA: BullishNov 19, 202511 months ago
SMA: BearishNov 7, 202511 months ago
MACD: Sell SignalOct 28, 20251 year ago
RSI: OverboughtOct 20, 20251 year ago
RSI: OverboughtOct 15, 20251 year ago
MACD: Buy SignalSep 30, 20251 year ago
MACD: Sell SignalSep 24, 20251 year ago
MACD: Buy SignalSep 19, 20251 year ago
MACD: Sell SignalSep 2, 20251 year ago
RSI: OverboughtAug 15, 20251 year ago
RSI: OverboughtAug 13, 20251 year ago
RSI: OverboughtAug 7, 20251 year ago
MACD: Buy SignalAug 6, 20251 year ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 29, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 21, 20251 year ago
MACD: Sell SignalJul 11, 20251 year ago
MACD: Buy SignalJun 25, 20251 year ago
RSI: OverboughtJun 25, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
RSI: OverboughtJun 11, 20251 year ago
MACD: Buy SignalJun 3, 20251 year ago
MACD: Sell SignalMay 22, 20251 year ago
RSI: OverboughtMay 5, 20251 year ago
SMA: BullishMay 2, 20251 year ago
MACD: Buy SignalMay 2, 20251 year ago
MACD: Sell SignalMay 1, 20251 year ago
SMA: BearishApr 28, 20251 year ago
MACD: Buy SignalApr 25, 20251 year ago
SMA: BullishApr 24, 20251 year ago
MACD: Sell SignalApr 16, 20251 year ago
SMA: BearishApr 14, 20251 year ago
SMA: BullishApr 11, 20251 year ago
SMA: BearishApr 10, 20251 year ago
SMA: BullishApr 9, 20251 year ago
MACD: Buy SignalApr 9, 20251 year ago
SMA: BearishApr 3, 20251 year ago
SMA: BullishApr 2, 20251 year ago
MACD: Sell SignalMar 31, 20251 year ago
SMA: BearishMar 28, 20251 year ago
MACD: Buy SignalMar 21, 20251 year ago
SMA: BullishMar 20, 20251 year ago
SMA: BearishMar 13, 20251 year ago
SMA: BullishMar 12, 20251 year ago
SMA: BearishMar 7, 20251 year ago
MACD: Sell SignalFeb 21, 20251 year ago
MACD: Buy SignalFeb 14, 20251 year ago
MACD: Sell SignalFeb 4, 20251 year ago
MACD: Buy SignalJan 16, 20251 year ago
MACD: Sell SignalJan 13, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago
MACD: Sell SignalDec 19, 20241 year ago

Key statistics

Market cap
4.25B
Enterprise value
4.57B
Trailing P/E
0.00
Forward P/E
-147.76
PEG ratio
0.00
Price / sales
13.80
Price / book
29.67
EPS (TTM)
-0.41
Beta
2.10
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-20.73%
Revenue (TTM)
308.08M
Revenue growth
21.50%
Free cash flow
18.98M
Total cash
344.26M
Total debt
410.50M
Return on equity
-38.76%
Shares outstanding
159.60M
Short % of float
9.49%
50-day average
26.35
200-day average
19.56

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 30.21 +13.4% upside
Target (low)
21.00
Target (mean)
30.21
Target (high)
35.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate -0.09552.

Earnings history

Financials — quick view

All financials
ADPT Revenue — quarterly 71.55M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ADPT Net income — quarterly -39.79M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ADPT EPS — quarterly -0.25
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ADPT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 2026-0.09108———
Jul 28, 2026Jun 30, 2026-0.13361-0.25-0.12-87.11%
May 5, 2026Mar 31, 2026-0.16-0.13+0.03+18.75%
Feb 5, 2026Dec 31, 2025-0.19-0.09+0.10+52.63%
Nov 6, 2025Sep 30, 2025-0.180.06+0.24+133.33%
Aug 5, 2025Jun 30, 2025-0.24-0.17+0.07+29.17%

Upgrades / downgrades

ADPT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026TD CowenmainBuyBuy
Oct 13, 2026Morgan StanleymainEqual-WeightEqual-Weight
Oct 1, 2026GuggenheimmainBuyBuy
Sep 29, 2026Goldman Sachsinit—Buy
Sep 22, 2026BTIGmainBuyBuy
Aug 4, 2026Piper SandlermainOverweightOverweight

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States

News

Your note

Sign in to keep a note on ADPT — it syncs with the Stock Master app.

Insider holders

ADPT insider holders
InsiderRelationLatest transactionDateShares held
BENZENO SHARONOfficerSaleJun 28, 2026221,278
BOBULSKY SUSANOfficerSaleOct 5, 2026389,350
LO FRANCISOfficerSaleSep 30, 2026223,367
NEUPERT PETER MDirectorSaleAug 16, 2026130,625
OWEN KATEY EINTERZDirectorStock GiftAug 30, 202666,100
PELLINI MICHAEL JDirectorStock Award(Grant)Mar 3, 202569,690

Institution ownership

ADPT institution ownership
Holder% heldSharesValueReported
Viking Global Investors, L.P.18.79%29,993,708799.03MJun 29, 2026
Blackrock Inc.9.49%15,139,159403.31MJun 29, 2026
Vanguard Capital Management LLC4.01%6,403,587170.59MJun 29, 2026
Wellington Management Group, LLP3.70%5,911,366157.48MJun 29, 2026
Vanguard Portfolio Management LLC3.43%5,476,231145.89MJun 29, 2026
Shaw D.E. & Co., Inc.2.90%4,625,859123.23MJun 29, 2026

Fund ownership

ADPT fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.03%4,834,309128.79MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.58%4,122,023109.81MSep 29, 2026
ARK ETF Trust-ARK Genomic Revolution ETF1.14%1,825,33348.63MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.09%1,742,85446.43MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.06%1,684,99844.89MJul 30, 2026
ALGER FUNDS-Alger Small Cap Focus Fund0.94%1,494,21439.81MJul 30, 2026
Advertisement